Bruker Corporation 6.375% Mandatory Convertible Preferred Stock, Series A
General ticker "BRKRP" information:
- Sector: Health Care
- Industry: Medical - Devices
- Capitalization: $6.5B (TTM average)
Bruker Corporation 6.375% Mandatory Convertible Preferred Stock, Series A follows the US Stock Market performance with the rate: 40.1%.
Estimated limits based on current volatility of 1.3%: low 353.18$, high 362.45$
Factors to consider:
- Company pays dividends (irregularly): last record date 2025-11-15, amount 3.67$ (Y1.03%)
Short-term BRKRP quotes
Long-term BRKRP plot
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $2,530.70MM | $2,964.50MM | $3,366.40MM |
| Operating Expenses | $2,098.00MM | $2,527.60MM | $3,113.30MM |
| Operating Income | $432.70MM | $436.90MM | $253.10MM |
| Non-Operating Income | $-17.80MM | $109.30MM | $-47.90MM |
| Interest Expense | $16.10MM | $16.40MM | $47.90MM |
| R&D Expense | $235.90MM | $294.80MM | $376.50MM |
| Income(Loss) | $414.90MM | $546.20MM | $205.20MM |
| Taxes | $116.40MM | $117.70MM | $91.40MM |
| Profit(Loss)* | $296.60MM | $427.20MM | $113.10MM |
| Stockholders Equity | $1,113.80MM | $1,377.20MM | $1,781.20MM |
| Inventory | $800.10MM | $968.30MM | $1,067.80MM |
| Assets | $3,611.80MM | $4,249.90MM | $5,806.70MM |
| Operating Cash Flow | $274.40MM | $350.10MM | $251.30MM |
| Capital expenditure | $129.20MM | $106.90MM | $115.30MM |
| Investing Cash Flow | $-251.60MM | $-326.00MM | $-1,757.30MM |
| Financing Cash Flow | $-415.30MM | $-193.40MM | $1,229.80MM |
| Earnings Per Share** | $2.00 | $2.92 | $0.76 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.